Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
IN-TIME
IN-TIME: Influence of Home Monitoring on the Clinical Status of Heart Failure Patients
2 other identifiers
interventional
720
6 countries
38
Brief Summary
Re-hospitalizations or deaths by worsening heart failure are often preceded by distinct trends of clinical parameters such as atrial or ventricular arrhythmia, activity, heart rate variability, or ventricular ectopy. The Home Monitoring™ capability offered by BIOTRONIK active implants has the potential to detect some of these trends early and thus to offer the possibility to intervene in time for prevention of fatal worsening of heart failure. To investigate the predictive value of Home Monitoring parameters, patients with symptomatic heart failure and reduced ejection fraction receiving an implantable cardioverter-defibrillator (ICD) or an ICD in combination with cardiac resynchronization therapy (CRT-D) will be randomized between prospective patient management by Home Monitoring analysis or standard care. The influence of Home Monitoring on the clinical status of heart failure patients will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jul 2007
Longer than P75 for phase_4
38 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 1, 2007
CompletedFirst Posted
Study publicly available on registry
October 2, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedDecember 23, 2014
December 1, 2014
4.7 years
October 1, 2007
December 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite Score of death, hospitalization for heart failure, NYHA class and global assessment (Packer Score)
12 months
Secondary Outcomes (1)
Rehospitalizations due to worsening heart failure; Correlation of Home Monitoring values with the clinical status; Incidence and reasons for Home Monitoring based interventions; Home Monitoring workflow analysis
12 months
Study Arms (2)
Home Monitoring
EXPERIMENTALICD or CRT-D with Home Monitoring feature activated Home Monitoring data will be analyzed regularly and patients will be contacted and scheduled for additional follow-up after predefined events
Control
ACTIVE COMPARATORICD or CRT-D with Home Monitoring feature deactivated Patients will be treated as per standard of care in each participating clinic
Interventions
Standard care + patient management by Home Monitoring
Eligibility Criteria
You may qualify if:
- Indication for single chamber ICD, dual chamber ICD or CRT-D
- Chronic heart failure (≥ 3 months)
- NYHA Class II or III for 1 month prior to screening
- LVEF ≤ 35% within 3 months prior to screening
- Indication for therapy with diuretics
- Patient informed consent
You may not qualify if:
- Uncontrolled hypertension
- NYHA class I or IV
- Permanent atrial fibrillation
- Life expectancy \< 1 year
- Restrictive, infiltrative or hypertrophic cardiomyopathy, constrictive pericarditis, acute myocarditis
- Severe mitral regurgitation
- Symptomatic aortic stenosis
- Tricuspid valve replacement
- Known drug or alcohol abuse
- Expected non-compliance
- Pregnancy
- Participation in another telemonitoring concept
- Participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (39)
Sydney Adventist Hospital
Wahroonga, 2076, Australia
Universitätsklinik für Innere Medizin
Innsbruck, A-6020, Austria
Institute of Clinical and Experimental Medicine
Prague, 14021, Czechia
Hospital Na Homolce
Prague, 15030, Czechia
Aalborg Hospital
Aalborg, 9100, Denmark
Århus Universitetshospital, Skejby Sygehus
Århus N, 8200, Denmark
Gentofte Hospital
Hellerup, 2900, Denmark
Odense Universitets Hospital
Odense, 5000, Denmark
Zentralklinik Bad Berka
Bad Berka, 99437, Germany
Herz- und Gefäßklinikum Bad Neustadt GmbH
Bad Neustadt an der Saale, 97616, Germany
Bad Segeberger Kliniken GmbH
Bad Segeberg, 23795, Germany
Vivantes Klinikum Neukölln
Berlin, 04129, Germany
Vivantes Klinikum am Urban
Berlin, 10967, Germany
Universitätsklinikum Charité Campus Benjamin Franklin
Berlin, 12200, Germany
Vivantes Humboldt Klinikum
Berlin, 13509, Germany
Städtische Kliniken Bielefeld
Bielefeld, 22604, Germany
Universitätsklinikum Bonn
Bonn, 53105, Germany
Klinikum Coburg gGmbH
Coburg, 96450, Germany
Klinikum Lippe-Detmold
Detmold, 32756, Germany
Westdeutsches Herzzentrum des Universitätsklinikums Essen
Essen, 45122, Germany
Universitätsklinikum Gießen und Marburg
Giessen, 35392, Germany
Medizinische Hochschule
Hanover, 30625, Germany
Universitätsklinikum des Saarlandes
Homburg/Saar, 66421, Germany
Klinikum St. Georg gGmbH
Leipzig, 04129, Germany
Herzzentrum der Universität Leipzig
Leipzig, 04289, Germany
Universitätsklinik Schleswig-Holstein
Lübeck, 23538, Germany
St. Marienhospital Lünen GmbH
Lünen, 44534, Germany
Klinikum Schwabing, Kardiologie
Munich - Schwabing, Germany
Kardiologische Gemeinschaftspraxis Dr. Mühling
München, 80379, Germany
Stiftsklinik Augustinum, Innere Medizin / Kardiologie
München, 81375, Germany
Klinikum der Universität München Großhadern
München, 81377, Germany
Herzzentrum München-Bogenhausen
München, 81925, Germany
Kardiologische Gemeinschaftspraxis Dr. Predel, Dr. Heinrich
Nordhausen, 99734, Germany
St. Vincenz Krankenhaus GmbH
Paderborn, 33098, Germany
Klinikum Pirna GmbH
Pirna, 01796, Germany
Barzilai Medical Center
Ashkelon, 78306, Israel
Rabin Medical Center
Petah Tikva, 49100, Israel
Chaim Sheba Medical Center
Tel Litwinsky, 52621, Israel
P. Stradins Clinical University Hospital, Latvian Centre of Cardiology
Riga, Latvia
Related Publications (2)
Arya A, Block M, Kautzner J, Lewalter T, Mortel H, Sack S, Schumacher B, Sogaard P, Taborsky M, Husser D, Hindricks G; IN-TIME investigators. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study. Eur J Heart Fail. 2008 Nov;10(11):1143-8. doi: 10.1016/j.ejheart.2008.08.004. Epub 2008 Sep 19.
PMID: 18805053BACKGROUNDHindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Sogaard P; IN-TIME study group*. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014 Aug 16;384(9943):583-590. doi: 10.1016/S0140-6736(14)61176-4.
PMID: 25131977DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gerhard Hindricks, Prof. Dr.
Herzzentrum Leipzig, Germany
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2007
First Posted
October 2, 2007
Study Start
July 1, 2007
Primary Completion
March 1, 2012
Study Completion
August 1, 2013
Last Updated
December 23, 2014
Record last verified: 2014-12